Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study
Compared with HAIT alone, HAIT-M-P was associated with improved PFS and tumor response rates, and showed a possible trend toward improved OS in patients with locally aggressive erHCC, which warrants further validation.
Authors
- Weixin Luo (ORCID: https://orcid.org/0009-0002-4587-4329)
- Yansong Lin (ORCID: https://orcid.org/0000-0001-6095-4728)
- Rong Guo (ORCID: https://orcid.org/0000-0003-2799-3463)
- Wei Wei (ORCID: https://orcid.org/0000-0002-6762-7989)
- Wenping Lin (ORCID: https://orcid.org/0000-0001-5029-5466)
- Zhoutian Yang (ORCID: https://orcid.org/0009-0007-0261-8479)
- Jie Mei (ORCID: https://orcid.org/0009-0002-4490-3204)
- Fangyi Liu (ORCID: https://orcid.org/0000-0002-8675-0798)
- Jing‐Ping Yun
- Lixuan Liu
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-12
- DOI
- https://doi.org/10.3389/fimmu.2025.1643082
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00